Peer review reports
From: Malignancy in giant cell tumor of bone: analysis of an open-label phase 2 study of denosumab
Original Submission | ||
---|---|---|
1 Oct 2020 | Submitted | Original manuscript |
19 Oct 2020 | Reviewed | Reviewer Report - Michiel A.J. van de Sande |
4 Nov 2020 | Reviewed | Reviewer Report |
15 Nov 2020 | Author responded | Author comments - Emanuela Palmerini |
Resubmission - Version 2 | ||
15 Nov 2020 | Submitted | Manuscript version 2 |
18 Nov 2020 | Reviewed | Reviewer Report - Michiel A.J. van de Sande |
22 Nov 2020 | Reviewed | Reviewer Report |
7 Dec 2020 | Author responded | Author comments - Emanuela Palmerini |
Resubmission - Version 3 | ||
7 Dec 2020 | Submitted | Manuscript version 3 |
10 Dec 2020 | Author responded | Author comments - Emanuela Palmerini |
Resubmission - Version 4 | ||
10 Dec 2020 | Submitted | Manuscript version 4 |
Publishing | ||
15 Dec 2020 | Editorially accepted | |
22 Jan 2021 | Article published | 10.1186/s12885-020-07739-8 |